soul trial oral semaglutide cardiovascular outcomes 2024 results nejm and in... : New England Journal of Medicine The SOUL trial (Semaglutide Cardiovascular – SELECT Trial

For individuals in perimenopause, who may face increased cardiovascular risks, integrating our customized therapy into their weight loss program can lead to improved heart health and a reduced risk of serious health issues

VEGF Pathway and Retinal Angiogenesis Pathological ocular angiogenesis the basis of proliferative diabetic retinopathy (PDR), wet age-related macular degeneration (AMD), and retinopathy of prematurity (ROP) is predominantly driven by VEGF-A overexpression in response to tissue hypoxia, oxidative stress, and advanced glycation end-product (AGE) accumulation

And on tirzepatide, distinguishing between them matters for how you respond

The mitogenic activity of insulin is conserved across species and has been previously reported in growth plate chondrocytes from the fetal lamb 15